Oleh Suno India ditemui oleh Player FM dan komuniti kami - hak cipta dimiliki oleh penerbit, bukan Player FM, dan audio distrim secara langsung dari pelayan mereka. Tekan butang Langgan untuk mengesan kemas kini di Player FM, atau tampal suapan URL ke dalam aplikasi podcast lain.

People love us!

User reviews

"Suka fungsi luar talian"
"Ini merupakan "cara" untuk mengendalikan langganan podcast anda. Ia juga cara hebat untuk meneroka pdcast baru."

How the India’s booster dose scheme subverted drug approval procedures

37:00
 
Kongsi
 

Manage episode 335503635 series 2533765
Oleh Suno India ditemui oleh Player FM dan komuniti kami - hak cipta dimiliki oleh penerbit, bukan Player FM, dan audio distrim secara langsung dari pelayan mereka. Tekan butang Langgan untuk mengesan kemas kini di Player FM, atau tampal suapan URL ke dalam aplikasi podcast lain.

In celebration of 75 years of Independence, Prime Minister Narendra Modi announced free booster doses at government vaccination centres for 75 days from July 15 to September 30, 2022. A few days after this announcement, the news website The Wire published a shocking story on how the Central Drug Standards Control Organisation - the CDSCO - the country’s drug regulatory agency- never approved of precautionary doses.

In this episode, we speak to Banjot Kaur, the reporter who broke this important story this July. Early this year, a Telangana court asked The Wire to take down several articles related to vaccine policy based on a defamation suit by Bharat Biotech, which manufactures Covaxin. One of these stories pulled down was Banjot’s story. She has been writing on science and public health for 12 years, and has worked at Down to Earth Magazine and Times of India.

References

PM Modi's address to the nation
Exclusive: Nobody Approved India’s ‘Precautionary’ Doses – The Wire Science
Press briefing on the actions taken, preparedness and updates on COVID-19, Dated: 24.12.2021
10 Questions the Indian Govt Must Answer About Vaccines for Minors and Boosters
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
https://www.sunoindia.in/the-suno-india-show/why-a-covaxin-controversy-in-bhopal-is-worrying-trial-participants-activists-and-experts/

See sunoindia.in/privacy-policy for privacy information.

  continue reading

Bab

1. The Wire's story on how CDSCO did not approve (00:01:58)

2. Background of how PM's announcement was suspic (00:03:00)

3. Process of approving vaccine before its rolled (00:05:48)

4. Filing of RTI and its replies (00:08:26)

5. Questions unanswered by DGCI (00:16:16)

6. WHO suspends supply of Covaxin to UN agencies (00:24:06)

7. Nationalist pride on vaccine programme (00:29:40)

8. Necessary for journalists to raise questions (00:33:44)

340 episod

Kongsi
 
Manage episode 335503635 series 2533765
Oleh Suno India ditemui oleh Player FM dan komuniti kami - hak cipta dimiliki oleh penerbit, bukan Player FM, dan audio distrim secara langsung dari pelayan mereka. Tekan butang Langgan untuk mengesan kemas kini di Player FM, atau tampal suapan URL ke dalam aplikasi podcast lain.

In celebration of 75 years of Independence, Prime Minister Narendra Modi announced free booster doses at government vaccination centres for 75 days from July 15 to September 30, 2022. A few days after this announcement, the news website The Wire published a shocking story on how the Central Drug Standards Control Organisation - the CDSCO - the country’s drug regulatory agency- never approved of precautionary doses.

In this episode, we speak to Banjot Kaur, the reporter who broke this important story this July. Early this year, a Telangana court asked The Wire to take down several articles related to vaccine policy based on a defamation suit by Bharat Biotech, which manufactures Covaxin. One of these stories pulled down was Banjot’s story. She has been writing on science and public health for 12 years, and has worked at Down to Earth Magazine and Times of India.

References

PM Modi's address to the nation
Exclusive: Nobody Approved India’s ‘Precautionary’ Doses – The Wire Science
Press briefing on the actions taken, preparedness and updates on COVID-19, Dated: 24.12.2021
10 Questions the Indian Govt Must Answer About Vaccines for Minors and Boosters
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
https://www.sunoindia.in/the-suno-india-show/why-a-covaxin-controversy-in-bhopal-is-worrying-trial-participants-activists-and-experts/

See sunoindia.in/privacy-policy for privacy information.

  continue reading

Bab

1. The Wire's story on how CDSCO did not approve (00:01:58)

2. Background of how PM's announcement was suspic (00:03:00)

3. Process of approving vaccine before its rolled (00:05:48)

4. Filing of RTI and its replies (00:08:26)

5. Questions unanswered by DGCI (00:16:16)

6. WHO suspends supply of Covaxin to UN agencies (00:24:06)

7. Nationalist pride on vaccine programme (00:29:40)

8. Necessary for journalists to raise questions (00:33:44)

340 episod

Semua episod

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

Panduan Rujukan Pantas

Podcast Teratas